1. 2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Johanna; Mirza, Mansoor R.; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Vener... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Mirza, Mansoor R; Duan, Tao; Han, Xinwei; Zildjian, Sybil; Zografos, Elefthe... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1276-ESGO Pembrolizumab monotherapy for advanced clear cell gynaecological cancer: phase II PEACOCC trial. (20th October 2022) Authors: Miller, Rowan E; Clamp, Andrew; Gourley, Charlie; Roux, Rene; Hall, Marcia; Devlin, Michael-John; Nirsimloo, Rachel; Kounnis, Valentinos; Hughes, Laura; Counsell, Nicholas; Farrelly, Laura; Kristeleit, Rebecca S Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial. (20th October 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Kristeleit, Rebecca; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Miza, Mansoor R; Duan, Tao; Dong, Yuping; Zografos, Elefth... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer. (20th October 2022) Authors: Sun, Li; Sobocan, Monika; Rodriguez, Isabel V; Wei, Xia; Kalra, Ashwin; Oxley, Samuel; Sideris, Michail; Morgan, Robert D; Chandrasekaran, Dhivya; Rust, Kelly; Spiliopoulou, Pavlina; Miller, Rowan E; Crusz, Shanthini M; Lockley, Michelle; Singh, Naveena; Faruqi, Asma; Casey, Laura; Brockbank, Ell... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors. Issue 10 (31st October 2022) Authors: Davis, Elizabeth J; Martin-Liberal, Juan; Kristeleit, Rebecca; Cho, Daniel C; Blagden, Sarah P; Berthold, Dominik; Cardin, Dana B; Vieito, Maria; Miller, Rowan E; Hari Dass, Prashanth; Orcurto, Angela; Spencer, Kristen; Janik, John E; Clark, Jason; Condamine, Thomas; Pulini, Jennifer; Chen, Xueju... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 10(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeted therapies in gynaecological cancers. Issue 1 (17th December 2019) Authors: Crusz, Shanthini M; Miller, Rowan E Other Names: Singh Naveena guestEditor.; Gilks C Blake guestEditor. Journal: Histopathology Issue: Volume 76:Issue 1(2020) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions. (December 2020) Authors: Crusz, Shanthini M; El-Shakankery, Karim; Miller, Rowan E Journal: Women's health Issue: Volume 16(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The current state of pemetrexed in ovarian cancer. (September 2013) Authors: Miller, Rowan E; Banerjee, Susana Journal: Expert opinion on investigational drugs Issue: Volume 22:Number 9(2013:Sep.) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗